FFRangio System vs LVivo IQS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
FFRangio System
by CathWorks (acquired by Medtronic)
VS
LVivo IQS
by DiA Imaging Analysis

AI Verdict

The FFRangio System is designed for optimizing percutaneous coronary intervention (PCI) in coronary artery disease by providing wire-free FFR guidance through angiogram analysis. Conversely, LVivo IQS focuses on automating and enhancing ultrasound image analysis for evaluating global and segmental left and right ventricular function. While both are cardiology AI tools, they utilize different imaging modalities and address distinct clinical applications within cardiac diagnostics.

Choose FFRangio System if…

Choose the FFRangio System if your primary need is real-time, wire-free physiological assessment of coronary artery disease directly within the cath lab environment. This tool is ideal for optimizing and confirming percutaneous coronary intervention (PCI) decisions by providing accurate multi-vessel FFR results and advanced insights without the need for invasive pressure wires or vasoactive drugs.

View FFRangio System →

Choose LVivo IQS if…

Choose LVivo IQS if your focus is on enhancing the efficiency and diagnostic confidence of ultrasound image analysis, particularly for evaluating cardiac function. This AI-powered solution is best suited for automating the interpretation of echocardiograms, reducing variability in measurements like ejection fraction and strain, and providing real-time image quality feedback to help users acquire high-quality images.

View LVivo IQS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature FFRangio System LVivo IQS
Pricing Contact vendor for pricing information. Unknown
Deployment SaaS, on-prem, hybrid As an integrated part of an ultrasound and information technology (IT) system.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature FFRangio System LVivo IQS
Tool Name FFRangio System LVivo IQS
Company CathWorks DiA Imaging Analysis
Primary Clinical Application 3D FFR guidance for PCI decisions in coronary artery disease Automated ultrasound image analysis for diagnostic confidence and efficiency in cardiology
Core Technology/Methodology Wire-free and drug-free 3D FFR guidance using AI for angiogram analysis AI-powered real-time image quality feedback and automated analysis of ultrasound images
Key Output/Analysis Real-time FFRangio values, simulated pullback curve, lesion impact assessment, integrated sizing tool Global and segmental left ventricle (LV) function evaluation (ejection fraction, strain, wall motion), right ventricular (RV) function evaluation, bladder volume measurement
Eliminates/Reduces Eliminates the need for invasive pressure wires, drugs, or a guide catheter Reduces variability and increases efficiency in image interpretation

Videos

Demos, reviews, and walkthroughs featuring FFRangio System and LVivo IQS.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The FFRangio System is designed for wire-free and drug-free 3D FFR guidance to optimize PCI decisions for patients with coronary artery disease, utilizing C-arm angiography systems. In contrast, LVivo IQS offers AI-powered solutions to automate and enhance ultrasound image analysis for improved diagnostic confidence and efficiency in cardiology, focusing on global and segmental left and right ventricular function evaluation.
The FFRangio System provides real-time FFRangio values at every point on the coronary tree, simulated pullback curves, and a Lesion Impact feature to assess residual ischemia. LVivo IQS offers automated analysis of ultrasound images, including global and segmental left ventricle function (ejection fraction, strain, wall motion) and right ventricular function evaluation.
Yes, the FFRangio System explicitly eliminates the need for invasive pressure wires, drugs, or a guide catheter during FFR assessment. LVivo IQS enhances non-invasive ultrasound analysis, aiming to reduce variability and increase efficiency in image interpretation, thereby supporting clinical decision-making.
The FFRangio System is ISO 27001 certified for information security, and while it handles PHI, its HIPAA compliance is not explicitly stated as known. LVivo IQS is stated to be HIPAA compliant and implies a Business Associate Agreement (BAA) given its handling of PHI.
The FFRangio System uses artificial intelligence to aid in quick angiogram analysis and provide advanced insights for optimizing PCI decisions. LVivo IQS utilizes AI for real-time image quality feedback and automated analysis of ultrasound images, aiming to reduce variability and increase efficiency in image interpretation.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring FFRangio System or LVivo IQS

Backers

Who funded each tool's parent company.

LVivo IQS

AI Tool Finder
AI-powered search. Results may not be comprehensive.